Katzmarzyk Peter T, Mire Emily F, Horswell Ronald, Chu San T, Zhang Dachuan, Martin Corby K, Newton Robert L, Apolzan John W, Price-Haywood Eboni G, Fort Dan, Carton Thomas W, Denstel Kara D
Pennington Biomedical Research Center Baton Rouge Louisiana USA.
Ochsner Xavier Institute for Health Equity and Research New Orleans Louisiana USA.
Obes Sci Pract. 2024 Oct 19;10(5):e70017. doi: 10.1002/osp4.70017. eCollection 2024 Oct.
Short-term weight loss is possible in a variety of settings. However, long-term, free-living weight loss maintenance following structured weight loss interventions remains elusive.
The purpose was to study body weight trajectories over 2 years of intensive lifestyle intervention (ILI) and up to 4 years of follow-up versus usual care (UC).
Data were obtained from electronic medical records (EMRs) from participating clinics. Baseline (Day 0) was established as the EMR data point closest but prior to the baseline date of the trial. The sample included 111 ILI and 196 UC patients. The primary statistical analysis focused on differentiating weight loss trajectories between ILI and UC.
The ILI group experienced significantly greater weight loss compared with the UC group from Day 100 to Day 700, beyond which there were no significant differences. Intensive lifestyle intervention patients who maintained ≥5% and ≥10% weight loss at 24 months demonstrated significantly greater weight loss ( < 0.001) across the active intervention and follow-up.
Following 24 months of active intervention, patients with ILI regained weight toward their baseline to the point where ILI versus UC differences were no longer statistically or clinically significant. However, patients in the ILI who experienced ≥5% or ≥10% weight loss at the cessation of the active intervention maintained greater weight loss at the end of the follow-up phase.
ClinicalTrials.gov: NCT02561221.
在各种情况下都有可能实现短期体重减轻。然而,在结构化减肥干预后长期自由生活状态下维持体重减轻仍然难以实现。
旨在研究强化生活方式干预(ILI)2年及长达4年随访与常规护理(UC)相比的体重变化轨迹。
数据来自参与研究的诊所的电子病历(EMR)。将基线(第0天)确定为最接近但早于试验基线日期的EMR数据点。样本包括111名ILI患者和196名UC患者。主要统计分析集中于区分ILI和UC之间的体重减轻轨迹。
从第100天到第700天,ILI组的体重减轻明显大于UC组,在此之后两组无显著差异。在24个月时体重减轻≥5%和≥10%的强化生活方式干预患者在整个积极干预和随访期间体重减轻明显更多(<0.001)。
经过24个月的积极干预后,ILI患者的体重恢复至基线水平,此时ILI与UC之间的差异在统计学或临床上不再显著。然而,在积极干预结束时体重减轻≥5%或≥10%的ILI患者在随访阶段结束时维持了更多的体重减轻。
ClinicalTrials.gov:NCT02561221。